Botox and Botox Cosmetic (Botulinum toxin Type A) and Myobloc (Botulinum toxin Type B) have been linked in some cases to adverse reactions, including respiratory failure and death, following treatment of a variety of conditions using a wide range of doses, according to the FDA. The most severe adverse effects were found in children treated for spasticity in their limbs associated with cerebral palsy.